Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (101)Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy
Preheader (49)Skip to content Skip to navigation Skip to footer
Typography
sans
Colors
Text Analysis
Body Words420
Subject Words15
Body Emojis1
Subject Emojis
Media Analysis
Text Links153
Image Links6
Total Links159
Images10
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px4192 px
X-Spam Score-0.5
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEarly Morning

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy

Skip to content Skip to navigation Skip to footer
Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy